-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2021 to 2023.
- KalVista Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending January 31, 2024 was -0.84 USD/shares, a 12% decline year-over-year.
- KalVista Pharmaceuticals, Inc. Earnings Per Share, Diluted for the twelve months ending January 31, 2024 was -3.12 USD/shares, a 12.6% increase year-over-year.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2022 was -3.33 USD/shares, a 0.89% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2021 was -3.36 USD/shares, a 38.8% decline from 2020.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2020 was -2.42 USD/shares, a 47.6% decline from 2019.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)